{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T23:03:22Z","timestamp":1785366202657,"version":"3.55.0"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:00:00Z","timestamp":1772582400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82572418"],"award-info":[{"award-number":["82572418"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82372123"],"award-info":[{"award-number":["82372123"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016692","name":"Key Research and Development Program of Ningxia","doi-asserted-by":"publisher","award":["2023BEG02001"],"award-info":[{"award-number":["2023BEG02001"]}],"id":[{"id":"10.13039\/100016692","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012165","name":"Key Technologies Research and Development Program","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012165","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013365","name":"West China Hospital of Sichuan University","doi-asserted-by":"publisher","award":["ZYYC23004"],"award-info":[{"award-number":["ZYYC23004"]}],"id":[{"id":"10.13039\/501100013365","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004912","name":"Sichuan University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004912","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2023YFB3810000"],"award-info":[{"award-number":["2023YFB3810000"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioactive Materials"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.bioactmat.2026.03.012","type":"journal-article","created":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T07:10:54Z","timestamp":1773299454000},"page":"263-281","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Chronic inflammation-responsive hydrogel restores myeloid-T cell crosstalk to reinvigorate antitumor immunity against metastatic colorectal cancer"],"prefix":"10.1016","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3695-0134","authenticated-orcid":false,"given":"Xinchao","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-5920-6745","authenticated-orcid":false,"given":"Wangxian","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-3260-4005","authenticated-orcid":false,"given":"Hao","family":"Le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingjie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1344-1062","authenticated-orcid":false,"given":"Xiaorong","family":"Kou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liping","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-4690-4270","authenticated-orcid":false,"given":"Yangsong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-1587-1335","authenticated-orcid":false,"given":"Jiayi","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinmao","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0123-4311","authenticated-orcid":false,"given":"Peng","family":"Mi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zichao","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2913-0891","authenticated-orcid":false,"given":"Changyang","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioactmat.2026.03.012_bib1","first-page":"372","article-title":"Clinical management of metastatic colorectal cancer in the era of precision medicine","volume":"72","author":"Ciardiello","year":"2022","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.bioactmat.2026.03.012_bib2","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/s41575-022-00736-1","article-title":"Therapeutic landscape and future direction of metastatic colorectal cancer","volume":"20","author":"Bando","year":"2023","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bioactmat.2026.03.012_bib3","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/s41571-021-00495-z","article-title":"Precision oncology in metastatic colorectal cancer - from biology to medicine","volume":"18","author":"Di Nicolantonio","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.bioactmat.2026.03.012_bib4","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","article-title":"The evolving tumor microenvironment from cancer initiation to metastatic outgrowth","volume":"41","author":"de Visser","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bioactmat.2026.03.012_bib5","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.trecan.2020.02.022","article-title":"Turning cold into hot: firing up the tumor microenvironment","volume":"6","author":"Duan","year":"2020","journal-title":"Trends Cancer"},{"key":"10.1016\/j.bioactmat.2026.03.012_bib6","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1158\/2159-8290.CD-20-1808","article-title":"Therapeutic targeting of the tumor microenvironment","volume":"11","author":"Bejarano","year":"2021","journal-title":"Cancer Discov."},{"key":"10.1016\/j.bioactmat.2026.03.012_bib7","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.308","article-title":"Understanding cell-cell communication and signaling in the colorectal cancer microenvironment","volume":"11","author":"AlMusawi","year":"2021","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.bioactmat.2026.03.012_bib8","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.trecan.2023.06.010","article-title":"Perivascular niches: critical hubs in cancer evolution","volume":"9","author":"Nowosad","year":"2023","journal-title":"Trends Cancer"},{"key":"10.1016\/j.bioactmat.2026.03.012_bib9","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.trecan.2022.07.002","article-title":"Inflammation: the incubator of the tumor microenvironment","volume":"8","author":"Denk","year":"2022","journal-title":"Trends Cancer"},{"key":"10.1016\/j.bioactmat.2026.03.012_bib10","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.cell.2010.01.025","article-title":"Immunity, inflammation, and cancer","volume":"140","author":"Grivennikov","year":"2010","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.bioactmat.2026.03.012_bib11","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/s41392-021-00658-5","article-title":"Inflammation and tumor progression: signaling pathways and targeted intervention","volume":"6","author":"Zhao","year":"2021","journal-title":"Signal. Transduct. Tar."},{"key":"10.1016\/j.bioactmat.2026.03.012_bib12","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.coi.2007.02.001","article-title":"Cancer immunosurveillance, immunoediting and inflammation: independent or interdependent processes?","volume":"19","author":"Bui","year":"2007","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.bioactmat.2026.03.012_bib13","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/s41586-022-04735-9","article-title":"Neoantigen quality predicts immunoediting in survivors of pancreatic cancer","volume":"606","author":"Luksza","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.bioactmat.2026.03.012_bib14","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41571-018-0142-8","article-title":"Cancer immunoediting and resistance to T cell-based immunotherapy","volume":"16","author":"O'Donnell","year":"2019","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.bioactmat.2026.03.012_bib15","first-page":"228","article-title":"Reversing cancer immunoediting phases with a tumor-activated and optically reinforced immunoscaffold","volume":"35","author":"Li","year":"2024","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.bioactmat.2026.03.012_bib16","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/s41571-020-00459-9","article-title":"Targeting cancer-promoting inflammation - have anti-inflammatory therapies come of age?","volume":"18","author":"Hou","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.bioactmat.2026.03.012_bib17","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/nrc2809","article-title":"Eicosanoids and cancer","volume":"10","author":"Wang","year":"2010","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bioactmat.2026.03.012_bib18","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1053\/j.gastro.2021.09.059","article-title":"Cyclooxygenases and prostaglandins in tumor immunology and microenvironment of gastrointestinal cancer","volume":"161","author":"Wang","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bioactmat.2026.03.012_bib19","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/j.cell.2015.08.015","article-title":"Cyclooxygenase-dependent tumor growth through evasion of immunity","volume":"162","author":"Zelenay","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.bioactmat.2026.03.012_bib20","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s00281-012-0342-8","article-title":"Multifaceted roles of PGE2 in inflammation and cancer","volume":"35","author":"Nakanishi","year":"2013","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.bioactmat.2026.03.012_bib21","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1172\/JCI16492","article-title":"Cancer-associated immunodeficiency and dendritic cell abnormalities mediated by the prostaglandin EP2 receptor","volume":"111","author":"Yang","year":"2003","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.bioactmat.2026.03.012_bib22","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.cell.2018.01.004","article-title":"NK cells stimulate recruitment of cDC1 into the tumor microenvironment promoting cancer immune control","volume":"172","author":"B\u00f6ttcher","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.bioactmat.2026.03.012_bib23","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202012798","article-title":"Reprogramming immunosuppressive myeloid cells facilitates immunotherapy for colorectal cancer","volume":"13","author":"Lu","year":"2021","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.bioactmat.2026.03.012_bib24","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.immuni.2020.10.020","article-title":"Antagonistic inflammatory phenotypes dictate tumor fate and response to immune checkpoint blockade","volume":"53","author":"Bonavita","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.bioactmat.2026.03.012_bib25","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/j.immuni.2023.05.011","article-title":"Tumor-derived prostaglandin E2 programs cDC1 dysfunction to impair intratumoral orchestration of anti-cancer T cell responses","volume":"56","author":"Bayerl","year":"2023","journal-title":"Immunity"},{"key":"10.1016\/j.bioactmat.2026.03.012_bib26","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1038\/s41467-022-29026-9","article-title":"Cell death-induced immunogenicity enhances chemoimmunotherapeutic response by converting immune-excluded into T-cell inflamed bladder tumors","volume":"13","author":"Nikolos","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioactmat.2026.03.012_bib27","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/s41586-024-07254-x","article-title":"PGE2 limits effector expansion of tumour-infiltrating stem-like CD8+ T cells","volume":"629","author":"Lacher","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.bioactmat.2026.03.012_bib28","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/s41591-020-0805-8","article-title":"Neoadjuvant immunotherapy leads to pathological responses in MMR-proficient and MMR-deficient early-stage colon cancers","volume":"26","author":"Chalabi","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.bioactmat.2026.03.012_bib29","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1001\/jamaoncol.2021.2193","article-title":"Effect of celecoxib vs placebo as adjuvant therapy on disease-free survival among patients with breast cancer the REACT randomized clinical trial","volume":"7","author":"Coombes","year":"2021","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.bioactmat.2026.03.012_bib30","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1016\/j.immuni.2022.07.001","article-title":"Lung fibroblasts facilitate pre-metastatic niche formation by remodeling the local immune microenvironment","volume":"55","author":"Gong","year":"2022","journal-title":"Immunity"},{"key":"10.1016\/j.bioactmat.2026.03.012_bib31","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1001\/jama.2021.2454","article-title":"Effect of celecoxib vs placebo added to standard adjuvant therapy on disease-free survival among patients with stage III Colon cancer the CALGB\/SWOG 80702 (Alliance) randomized clinical trial","volume":"325","author":"Meyerhardt","year":"2021","journal-title":"Jama-J. Am. Med. Assoc."},{"key":"10.1016\/j.bioactmat.2026.03.012_bib32","doi-asserted-by":"crossref","first-page":"2602","DOI":"10.1158\/2159-8290.CD-20-1815","article-title":"Anti-inflammatory drugs remodel the tumor immune environment to enhance immune checkpoint blockade efficacy","volume":"11","author":"Pelly","year":"2021","journal-title":"Cancer Discov."},{"key":"10.1016\/j.bioactmat.2026.03.012_bib33","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/s41577-021-00534-x","article-title":"The inflammatory pathogenesis of colorectal cancer","volume":"21","author":"Schmitt","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bioactmat.2026.03.012_bib34","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/s41586-023-06685-2","article-title":"IL-1\u03b2+ macrophages fuel pathogenic inflammation in pancreatic cancer","volume":"623","author":"Caronni","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.bioactmat.2026.03.012_bib35","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/s41577-021-00540-z","article-title":"Fibroblasts as immune regulators in infection, inflammation and cancer","volume":"21","author":"Davidson","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bioactmat.2026.03.012_bib36","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nrd1755","article-title":"Future of COX2 inhibitors","volume":"4","author":"Melnikova","year":"2005","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bioactmat.2026.03.012_bib37","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1073\/pnas.1612920114","article-title":"COX2\/mPGES1\/PGE2 pathway regulates PD-L1 expression in tumor-associated macrophages and myeloid-derived suppressor cells","volume":"114","author":"Prima","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bioactmat.2026.03.012_bib38","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/s41586-024-07352-w","article-title":"PGE2 inhibits TIL expansion by disrupting IL-2 signalling and mitochondrial function","author":"Morotti","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.bioactmat.2026.03.012_bib39","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.it.2023.01.004","article-title":"Harnessing prostaglandin E2 signaling to ameliorate autoimmunity","volume":"44","author":"Burkett","year":"2023","journal-title":"Trends Immunol."},{"key":"10.1016\/j.bioactmat.2026.03.012_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2023.122444","article-title":"A programmable releasing versatile hydrogel platform boosts systemic immune responses via sculpting tumor immunogenicity and reversing tolerogenic dendritic cells","volume":"305","author":"Fu","year":"2024","journal-title":"Biomaterials"},{"key":"10.1016\/j.bioactmat.2026.03.012_bib41","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.trecan.2018.09.001","article-title":"The role of type 1 conventional dendritic cells in cancer immunity","volume":"4","author":"B\u00f6ttcher","year":"2018","journal-title":"Trends Cancer"},{"key":"10.1016\/j.bioactmat.2026.03.012_bib42","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/j.immuni.2021.04.019","article-title":"The inhibitory receptor TIM-3 limits activation of the cGAS-STING pathway in intra-tumoral dendritic cells by suppressing extracellular DNA uptake","volume":"54","author":"Pulido","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.bioactmat.2026.03.012_bib43","first-page":"527","article-title":"Exosome-guided direct reprogramming of tumor-associated macrophages from protumorigenic to antitumorigenic to fight cancer","volume":"25","author":"Kim","year":"2023","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.bioactmat.2026.03.012_bib44","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/s41590-022-01398-6","article-title":"YTHDF2 orchestrates tumor-associated macrophage reprogramming and controls antitumor immunity through CD8+ T cells","volume":"24","author":"Ma","year":"2023","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.bioactmat.2026.03.012_bib45","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1038\/s41565-021-00988-z","article-title":"A lysosome-targeted DNA nanodevice selectively targets macrophages to attenuate tumours","volume":"16","author":"Cui","year":"2021","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.bioactmat.2026.03.012_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111828","article-title":"Alveolar macrophages instruct CD8+T cell expansion by antigen cross-presentation in lung","volume":"41","author":"Kawasaki","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.bioactmat.2026.03.012_bib47","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1186\/s12951-024-02598-y","article-title":"Dual depletion of myeloid-derived suppressor cells and tumor cells with self-assembled gemcitabine-celecoxib nano-twin drug for cancer chemoimmunotherapy","volume":"22","author":"Zhang","year":"2024","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.bioactmat.2026.03.012_bib48","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ccell.2024.11.003","article-title":"Mannose metabolism reshapes T cell differentiation to enhance anti-tumor immunity","volume":"43","author":"Qiu","year":"2025","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bioactmat.2026.03.012_bib49","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1016\/j.immuni.2023.09.011","article-title":"The cancer-immunity cycle: indication, genotype, and immunotype","volume":"56","author":"Mellman","year":"2023","journal-title":"Immunity"},{"key":"10.1016\/j.bioactmat.2026.03.012_bib50","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1038\/s41586-024-08257-4","article-title":"Cancer cells impair monocyte-mediated T cell stimulation to evade immunity","volume":"637","author":"Elewaut","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.bioactmat.2026.03.012_bib51","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1053\/j.gastro.2019.11.013","article-title":"Prostaglandin E2 induces miR675-5p to promote colorectal tumor metastasis via modulation of p53 expression","volume":"158","author":"Cen","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bioactmat.2026.03.012_bib52","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1158\/2159-8290.CD-21-0316","article-title":"Spatiotemporal immune landscape of colorectal cancer liver metastasis at single-cell level","volume":"12","author":"Wu","year":"2022","journal-title":"Cancer Discov."},{"key":"10.1016\/j.bioactmat.2026.03.012_bib53","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/s42255-023-00736-8","article-title":"PFKFB2-mediated glycolysis promotes lactate-driven continual efferocytosis by macrophages","volume":"5","author":"Schilperoort","year":"2023","journal-title":"Nat. Metab."},{"key":"10.1016\/j.bioactmat.2026.03.012_bib54","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.molcel.2021.12.006","article-title":"Citrulline depletion by ASS1 is required for proinflammatory macrophage activation and immune responses","volume":"82","author":"Mao","year":"2022","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bioactmat.2026.03.012_bib55","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1038\/s41467-021-22923-5","article-title":"A Stat1 bound enhancer promotes Nampt expression and function within tumor associated macrophages","volume":"12","author":"Huffaker","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioactmat.2026.03.012_bib56","article-title":"Uncovering therapeutic targets for macrophage-mediated T cell suppression and PD-L1 therapy sensitization","volume":"5","author":"Kumar","year":"2024","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.bioactmat.2026.03.012_bib57","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1038\/s41565-022-01225-x","article-title":"Zinc cyclic di-AMP nanoparticles target and suppress tumours via endothelial STING activation and tumour-associated macrophage reinvigoration","volume":"17","author":"Yang","year":"2022","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.bioactmat.2026.03.012_bib58","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1016\/j.immuni.2023.06.007","article-title":"TCR-independent CD137 (4-1BB) signaling promotes CD8+-exhausted T cell proliferation and terminal differentiation","volume":"56","author":"Pichler","year":"2023","journal-title":"Immunity"},{"key":"10.1016\/j.bioactmat.2026.03.012_bib59","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/s41577-021-00566-3","article-title":"Interferon-\u03b3: teammate or opponent in the tumour microenvironment?","volume":"22","author":"Gocher","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bioactmat.2026.03.012_bib60","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1016\/j.cclet.2021.11.048","article-title":"Recent advances in enhancing reactive oxygen species based chemodynamic therapy","volume":"33","author":"Li","year":"2022","journal-title":"Chin. Chem. Lett."},{"key":"10.1016\/j.bioactmat.2026.03.012_bib61","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/s41568-021-00383-9","article-title":"The immunological and metabolic landscape in primary and metastatic liver cancer","volume":"21","author":"Li","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bioactmat.2026.03.012_bib62","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/j.ccell.2021.10.008","article-title":"Myeloid antigen-presenting cell niches sustain antitumor cells and license PD-1 blockade via CD28 costimulation","volume":"39","author":"Duraiswamy","year":"2021","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bioactmat.2026.03.012_bib63","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/s41467-024-44689-2","article-title":"Prostaglandin E2 controls the metabolic adaptation of T cells to the intestinal microenvironment","volume":"15","author":"Villa","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioactmat.2026.03.012_bib64","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1016\/j.ccell.2023.09.014","article-title":"In vivo macrophage engineering reshapes the tumor microenvironment leading to eradication of liver metastases","volume":"41","author":"Kerzel","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bioactmat.2026.03.012_bib65","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.ccell.2022.02.013","article-title":"Immune phenotypic linkage between colorectal cancer and liver metastasis","volume":"40","author":"Liu","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bioactmat.2026.03.012_bib66","doi-asserted-by":"crossref","first-page":"5309","DOI":"10.1016\/j.cell.2021.09.020","article-title":"Hallmarks of response, resistance, and toxicity to immune checkpoint blockade","volume":"184","author":"Morad","year":"2021","journal-title":"Cell"}],"container-title":["Bioactive Materials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452199X26001428?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452199X26001428?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T07:46:35Z","timestamp":1780991195000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452199X26001428"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":66,"alternative-id":["S2452199X26001428"],"URL":"https:\/\/doi.org\/10.1016\/j.bioactmat.2026.03.012","relation":{},"ISSN":["2452-199X"],"issn-type":[{"value":"2452-199X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chronic inflammation-responsive hydrogel restores myeloid-T cell crosstalk to reinvigorate antitumor immunity against metastatic colorectal cancer","name":"articletitle","label":"Article Title"},{"value":"Bioactive Materials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioactmat.2026.03.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd.","name":"copyright","label":"Copyright"}]}}